BioCentury | Jun 28, 2019
Company News

June 27 Company Quick Takes: Zogenix soars; plus Gardasil, Darzalex, Soliris and more

...JNJ-54767414, humax-cd38) Doptelet, avatrombopag (AKR-501, E5501) Gardasil 9 (V503) MabThera, Rituxan, rituximab (R105, RG105, IDEC-C2B8) NanoFlu Soliris, eculizumab (5G1.1) Alexion Pharmaceuticals Inc. Alliance for Lupus Research (ALR) Bristol-Myers...
BioCentury | Oct 14, 2013
Company News

Alliance for Lupus Research (ALR), Lupus Research Institute news

...The partners will make the list of drugs available to the research community by 1Q14. Alliance for Lupus Research (ALR)...
BioCentury | Nov 19, 2012
Company News

Pfizer, Alliance for Lupus Research (ALR) deal

...royalties on advanced programs (see BioCentury, Nov. 22, 2010). Pfizer Inc. (NYSE:PFE), New York, N.Y. Alliance for Lupus Research (ALR)...
BioCentury | Jan 17, 2005
Company News

Dynavax other research news

...DVAX announced that the Alliance for Lupus Research (ALR) awarded a $500,000 grant to explore new treatment approaches for SLE...
Items per page:
1 - 4 of 4
BioCentury | Jun 28, 2019
Company News

June 27 Company Quick Takes: Zogenix soars; plus Gardasil, Darzalex, Soliris and more

...JNJ-54767414, humax-cd38) Doptelet, avatrombopag (AKR-501, E5501) Gardasil 9 (V503) MabThera, Rituxan, rituximab (R105, RG105, IDEC-C2B8) NanoFlu Soliris, eculizumab (5G1.1) Alexion Pharmaceuticals Inc. Alliance for Lupus Research (ALR) Bristol-Myers...
BioCentury | Oct 14, 2013
Company News

Alliance for Lupus Research (ALR), Lupus Research Institute news

...The partners will make the list of drugs available to the research community by 1Q14. Alliance for Lupus Research (ALR)...
BioCentury | Nov 19, 2012
Company News

Pfizer, Alliance for Lupus Research (ALR) deal

...royalties on advanced programs (see BioCentury, Nov. 22, 2010). Pfizer Inc. (NYSE:PFE), New York, N.Y. Alliance for Lupus Research (ALR)...
BioCentury | Jan 17, 2005
Company News

Dynavax other research news

...DVAX announced that the Alliance for Lupus Research (ALR) awarded a $500,000 grant to explore new treatment approaches for SLE...
Items per page:
1 - 4 of 4